PP_1170x120_10-25-21

pharmacy DIR fee reform

204 pharmacy stakeholder groups urge senate finance to fix DIR

204 pharmacy stakeholder groups urge senate finance to fix DIR

ALEXANDRIA, Va.  — Support for pharmacy direct and indirect remuneration fee reform continues to grow, with 204 pharmacy stakeholder and patient advocacy groups urging the Senate Finance Committee to include pharmacy DIR fee reform in its forthcoming drug pricing legislation. Nearly a quarter of the U.S. House of Representatives and more than a quarter of

Adheris Health